{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T02:26:59Z","timestamp":1697509619851},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.2169\/internalmedicine.6458-20","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T22:25:05Z","timestamp":1610058305000},"page":"1717-1722","source":"Crossref","is-referenced-by-count":4,"title":["A Superinfection of &lt;i&gt;Salmonella typhi&lt;\/i&gt; and Hepatitis E Virus Causes Biphasic Acute Hepatitis"],"prefix":"10.2169","volume":"60","author":[{"given":"Takeshi","family":"Suda","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Medical & Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, National Hospital Organization Shizuoka Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Ishiyama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Medicine Section, St. Louis University, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Kanefuji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tsubame Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Hoshi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Medical & Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Medical & Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Medical & Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Medical & Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mogasale V, Maskery B, Ochiai RL, et al. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Health 2: e570-e580, 2014.","DOI":"10.1016\/S2214-109X(14)70301-8"},{"key":"2","unstructured":"2. WHO. Background paper to SAGE on Typhoid Policy Recommendations 2017 [Internet]. [cited 2020 Oct 5]. Available from: https:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/1_Typhoid_SAGE_background_paper_Final_v3B.pdf?ua=1."},{"key":"3","unstructured":"3. Levine MM. Typhoid fever vaccines. In: Plotkin&apos;s Vaccines. 7th ed. Plotkin SA, Orenstein WA, Offit PA, Edwards KM, Eds. WB Saunders, Philadelphia, 2017: 44e9."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gibani MM, Britto C, Pollard AJ. Typhoid and paratyphoid fever: a call to action. Curr Opin Infect Dis 31: 440-448, 2018.","DOI":"10.1097\/QCO.0000000000000479"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med 347: 1770-1782, 2002.","DOI":"10.1056\/NEJMra020201"},{"key":"6","unstructured":"6. Khosla SN, Singh R, Singh GP, Trehan VK. The spectrum of hepatic injury in enteric fever. Am J Gastroenterol 83: 413-416, 1988."},{"key":"7","unstructured":"7. Morgenstern R, Hayes PC. The liver in typhoid fever: always affected, not just a complication. Am J Gastroenterol 86: 1235-1239, 1991."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Donnelly MC. Scobie L, Crossan CL, et al. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther 46: 126-141, 2017.","DOI":"10.1111\/apt.14109"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128, 2012.","DOI":"10.1016\/S0140-6736(12)61728-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 55: 988-997, 2012.","DOI":"10.1002\/hep.25505"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Albinana-Gimenez N, Clemente-Casares P, Bofill-Mas S, Hundesa A, Ribas F, Girones R. Distribution of human polyomaviruses, adenoviruses, and hepatitis E virus in the environment and in a drinking-water treatment plant. Environ Sci Technol 40: 7416-7422, 2006.","DOI":"10.1021\/es060343i"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gupta N, Sarangi AN, Dadhich S, Dixit VK, Chetri K, Goel A, et al. Acute hepatitis E in India appears to be caused exclusively by genotype 1 hepatitis E virus. Indian J Gastroenterol 37: 44-49, 2018.","DOI":"10.1007\/s12664-018-0819-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Donnelly MC, Scobie L, Crossan CL, Dalton H, Hayes PC, Simpson KJ. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther 46: 126-141, 2017.","DOI":"10.1111\/apt.14109"},{"key":"14","unstructured":"14. Viswanathan R. Infectious hepatitis in Delhi (1955-56): a critical study-epidemiology. 1957. Natl Med J India 26: 362-377, 2013."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 147: 28-33, 2007.","DOI":"10.7326\/0003-4819-147-1-200707030-00005"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 384: 1766-1773, 2014.","DOI":"10.1016\/S0140-6736(14)61034-5"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. El-Newihi HM, Alamy ME, Reynolds TB. Salmonella hepatitis: analysis of 27 cases and comparison with acute viral hepatitis. Hepatology 24: 516-519, 1996.","DOI":"10.1053\/jhep.1996.v24.pm0008781316"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Takahashi M, Kusakai S, Mizuo H, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection. J Clin Microbiol 43: 49-56, 2005.","DOI":"10.1128\/JCM.43.1.49-56.2005"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL. Typhoid fever. Lancet 385: 1136-1145, 2015.","DOI":"10.1016\/S0140-6736(13)62708-7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Koshiol J, Wozniak A, Cook P, et al. <i>Salmonella enterica<\/i> serovar Typhi and gallbladder cancer: a case-control study and meta-analysis. Cancer Med 5: 3310-3235, 2016.","DOI":"10.1002\/cam4.915"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mohan VK, Varanasi V, Singh A, et al. Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study. Clin Infect Dis 61: 393-402, 2015.","DOI":"10.1093\/cid\/civ295"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Jin C, Gibani MM, Moore M, et al. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of <i>Salmonella<\/i> Typhi: a randomised controlled, phase 2b trial. Lancet 390: 2472-2480, 2017.","DOI":"10.1016\/S0140-6736(17)32149-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mai NL, Phan VB, Vo AH, et al. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. N Engl J Med 349: 1390-1391, 2003.","DOI":"10.1056\/NEJM200310023491423"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hartl J, Otto B, Madden RG, et al. Hepatitis E seroprevalence in Europe: a meta-analysis. Viruses 8: 211-214, 2016.","DOI":"10.3390\/v8080211"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 82: 799-805, 2010.","DOI":"10.1002\/jmv.21656"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Fujiwara S, Yokokawa Y, Morino K, Hayasaka K, Kawabata M, Shimizu T. Chronic hepatitis E: a review of the literature. J Viral Hepat 21: 78-89, 2014.","DOI":"10.1111\/jvh.12156"},{"key":"27","unstructured":"27. Recombinant Hepatitis E Vaccine Disponible sur [Internet]. Available from: http:\/\/www.innovax.cn\/en\/pro1.aspx?CateID=52#103"},{"key":"28","unstructured":"28. Osler W. Hepatic complication of typhoid fever. Johns Hopkins Hosp Rep 8: 373-387, 1899."},{"key":"29","unstructured":"29. Hepatitis E Vaccine Working Group. Hepatitis E: epidemiology and disease burden. World Health Organization, Geneva, 2014."},{"key":"30","unstructured":"30. Smith MW, Schmidt JE, Rehg JE, Orihuela CJ, McCullers JA. Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. Comp Med 57: 82-89, 2007."},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Tashiro M, Ciborowski P, Klenk HD, Pulverer G, Rott R. Role of Staphylococcus protease in the development of influenza pneumonia. Nature 325: 536-537, 1987.","DOI":"10.1038\/325536a0"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/11\/60_6458-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T05:44:50Z","timestamp":1622871890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/11\/60_6458-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6458-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}